Public HealthMaternal HealthObstetricsMaternal Mental HealthPerinatal PsychiatryPsychopharmacologyMaternal Mental Health In PregnancyMaternal MorbidityPerinatal AnxietyPregnancyPregnancy-related AnxietyPrenatal CareAntidepressant Use In PregnancyAnxiety During PregnancyDepression During PregnancyDepression In PregnancyMaternal Mental Health DisordersMaternal Mood DisordersPharmacotherapy For Perinatal DepressionTreatment Of Perinatal Depression
The risk of depression in women is greatest during the child-bearing years. Considering that about 50% of pregnancies are unplanned, women may become pregnant while on antidepressants, may have their depression or anxiety relapse during pregnancy or postpartum, or may be unwell and untreated before and during pregnancy and the postpartum period. The impact of the symptoms of depression and anxiety can cause risk to the mother and also have a negative effect on child development. This presentation is intended to assist in understanding the impact of untreated maternal depression and anxiety on fetus, neonate, child and mother; to review the effects of fetal exposure to psychotropic medications (antidepressants); and to summarize general management of perinatal mood/anxiety disorders.
14
Birth Outcomes in Pregnant Women Taking Fluoxetine
Christina Chambers, Kathleen A. Johnson, Lyn M. Dick et al. · New England Journal of Medicine · 1996 · 738 citations · Full text
Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs
Irena Nulman, Joanne Rovet, Donna E. Stewart et al. · New England Journal of Medicine · 1997 · 578 citations · Full text
Medicine, Pediatrics, Psychiatry +17